CS Diagnostics Corp. (CSDX)
OTCMKTS
· Delayed Price · Currency is USD
0.2775
-0.1225 (-30.63%)
Apr 7, 2025, 9:30 AM EDT
CS Diagnostics Statistics
Total Valuation
CS Diagnostics has a market cap or net worth of 49.43 million.
Market Cap | 49.43M |
Enterprise Value | n/a |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
CS Diagnostics has 137.34 million shares outstanding.
Current Share Class | n/a |
Shares Outstanding | 137.34M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | -57.09% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.02
Current Ratio | 0.02 |
Quick Ratio | 0.02 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -316.07% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | 15.26% |
Revenue Per Employee | n/a |
Profits Per Employee | -341,611 |
Employee Count | 1 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +61.24% in the last 52 weeks. The beta is -20.31, so CS Diagnostics's price volatility has been lower than the market average.
Beta (5Y) | -20.31 |
52-Week Price Change | +61.24% |
50-Day Moving Average | 0.57 |
200-Day Moving Average | 1.20 |
Relative Strength Index (RSI) | 46.18 |
Average Volume (20 Days) | 26,921 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.14 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -298,049 |
Pretax Income | -341,611 |
Net Income | -341,611 |
EBITDA | -295,950 |
EBIT | -298,049 |
Earnings Per Share (EPS) | -3.54 |
Balance Sheet
The company has 37,378 in cash and n/a in debt, giving a net cash position of 37,378 or 0.00 per share.
Cash & Cash Equivalents | 37,378 |
Total Debt | n/a |
Net Cash | 37,378 |
Net Cash Per Share | 0.00 |
Equity (Book Value) | -1.95M |
Book Value Per Share | -20.23 |
Working Capital | -1.98M |
Cash Flow
Operating Cash Flow | -104 |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
CS Diagnostics does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -0.69% |
FCF Yield | n/a |
Stock Splits
The last stock split was on August 3, 2023. It was a reverse split with a ratio of 0.002.
Last Split Date | Aug 3, 2023 |
Split Type | Reverse |
Split Ratio | 0.002 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |